
Mometasone Furoate is a potent synthetic corticosteroid used for its anti-inflammatory and anti-allergic properties. Zyntex provides this high-purity API for advanced nasal sprays, inhalers, and topical dermatological products.
In the field of allergy management and chronic airway inflammation, the purity of the corticosteroid determines the safety profile and clinical success. Zyntex Mometasone Furoate is selected for its high affinity for glucocorticoid receptors and its unique metabolic pathway, which minimizes systemic exposure. It works primarily by inhibiting the release of pro-inflammatory mediators, thereby providing rapid relief from allergic rhinitis and asthma symptoms. Therefore, we provide a micronized API that is exceptionally suited for suspension-based delivery systems, ensuring uniform dosage and consistent patient outcomes.
Zyntex supplies Mometasone Furoate as a premium crystalline powder, optimized for easy integration into nasal spray pumps, pressurized metered-dose inhalers (pMDIs), and topical creams. Our stringent quality control measures ensure a high assay value and strictly controlled particle size distribution, meeting the highest global standards for respiratory medicine. Furthermore, this product features excellent chemical stability, ensuring the long-term integrity of the finished drug product. Since it is highly effective at microgram dosages, you can incorporate it into precision-engineered formulations without compromising the safety or tolerability of the treatment.
From specialized nasal health research to large-scale industrial pharmaceutical manufacturing, this modern corticosteroid is a staple for advanced anti-inflammatory solutions. Its consistent chemical profile ensures it does not interfere with the bioavailability of specialized excipients or preservatives. As a result, Zyntex provides a dependable foundation for innovation in the “respiratory-care” and “medical-dermatology” markets. Finally, our commitment to safety and high manufacturing standards helps your brand achieve international regulatory compliance and healthcare provider trust effortlessly.
This professional-grade corticosteroid API is widely utilized in the following sectors:
Primary active agent in treatments for seasonal and perennial allergic rhinitis and nasal polyps.
Used for formulating maintenance treatments for asthma and chronic obstructive pulmonary disease (COPD).
Incorporated into creams and ointments to treat corticosteroid-responsive dermatoses and psoriasis.
Serves as a high-purity reference standard for receptor binding studies and drug delivery optimization.
| Parameter | Specification Standard |
|---|---|
| Product Name | Mometasone Furoate |
| Grade | Pharmaceutical Grade (USP/EP) |
| Assay (Purity) | 98.0% – 102.0% |
| Appearance | White to Off-White Powder |
| CAS Number | 83919-23-7 |
🔬 Scientific Data: For detailed biochemical profile and safety studies consult: PubChem Entry: Mometasone Furoate (External Link)